🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hepatic Artery Infusion

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT NCT07327788Phase 21 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Iparomlimab and Tuvonralimab Injection (QL1706), Bevacizumab, Hepatic Arterial Infusion Chemotherapy with Raltitrexed a… Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma NCT03364530Phase 27 sites📍 Amiens📍 Angers📍 Bordeaux University Hospital, Montpellier · Tests: Gemcitabine-Oxaliplatin Regimen, Hepatic intra arterial chemotherapy Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy NCT07201519Phase 21 site📍 Lexington Michael J Cavnar, MD · Tests: Hepatic Artery Infusion Pump (HAIP), Standard Treatment, Community Treatment, Systemic Chemotherapy Standard of Care, S… Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors NCT07337460Phase 21 site📍 Yangzhou Northern Jiangsu People's Hospital · Tests: Icaritin Soft Capsules and mFOLFOX ：Oxaliplatin,leucovorin calcium,5-fluorouracil Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma NCT06406634Phase 21 site📍 Changsha Hunan Cancer Hospital · Tests: Cadonilimab, Lenvatinib Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC NCT06041477Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU, Concurrent Lenvatinib, Concurrent PD-1 antibody, Sequential L… Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial NCT05751343Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: TACE-HACI, plus atezolizumab-bevacizumab HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC NCT06632093n/a1 site📍 Shenyang First Hospital of China Medical University · Tests: hepatic artery infusion chemotherapy, Lenvatinib + PD-1 monoclonal antibody Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer NCT07636798Phase 1, Phase 21 site📍 Chengdu West China Hospital · Tests: HAIC Combined Regimen Treatment Group FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis NCT06988852Phase 21 site📍 Wuhan Tongji Hospital · Tests: FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU]), hepatic arterial infusion chemotherapy (HAIC), Bevacizumab, Cet… Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma NCT03949231Phase 31 site📍 Guanzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: PD1/PDL1 inhibitor Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy NCT07284836Phase 21 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Abraxane, Nedaplatin Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy NCT07436845n/a1 site📍 Guangzhou Nanfang Hospital, Southern Medical University Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT NCT06904183Phase 21 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: LEN+SIN+DEB-TACE+HAIC, LEN+SIN+DEB-TACE FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma NCT07012798Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Durvalumab, Bevacizumab, HAIC of FOLFOX Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial NCT07847359Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cryoablation, Iparomlimab and Tuvonralimab, Dacarbazine, Lenvatinib Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus NCT07776080Phase 21 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Iparomlimab and Tuvonralimab (QL1706), Lenvatinib, Radiotherapy, hepatic arterial infusion chemotherapy (HAIC) DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC NCT06397235Phase 21 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: DEB-TACE+HAIC, DEB-TACE Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases NCT04837885Phase 24 sites📍 Bordeaux📍 Nîmes📍 Pessac University Hospital, Bordeaux · Tests: Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection, Positron emission tomogra… Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases NCT07504471Phase 21 site📍 Shanghai Ruijin Hospital · Tests: pH-NASOX-Immune Group Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) NCT06859684Phase 21 site📍 Chengdu West China Hospital · Tests: Durvalumab, hepatic arterial infusion chemotherapy (HAIC), Lenvatinib HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma NCT06244225Phase 21 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Donafenib； Sintilimab； HAIC Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases NCT07117435Phase 11 site📍 Lishui CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: paclitaxel cationic liposome for injection, Oxaliplatin, Capecitabine, Bevacizumab Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial NCT07847710Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Retlirafusp alfa, Famitinib malate, Gemcitabine & oxaliplatin, Capecitabine, S-1 Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC) NCT06796803Phase 2, Phase 32 sites📍 Harbin📍 Shanghai Shanghai Zhongshan Hospital · Tests: camrelizumab combined with rivoceranib and HAIC, camerlizumab + rivoceranib HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma NCT06187961Phase 21 site📍 Wuhan Tongji Hospital · Tests: Hepatic arterial infusion chemotherapy (HAIC-FOLFOX), Lenvatinib, Cadonilimab Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial NCT07021534Phase 11 site📍 Hangzhou Zhejiang University · Tests: NKG2D CAR NK and NKG2D CAR T cells FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients NCT05727163Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Dexamethasone, Anisodamine, Oxaliplatin, Leucovorin, Fluorouracil Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy NCT06857773Phase 31 site📍 Amsterdam The Netherlands Cancer Institute · Tests: Intra arterial infusion Floxuridine (FUDR) combined with systemic therapy, Hepatic arterial infusion pump (HAIP), Syste… Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial NCT05863195Phase 362 sites📍 Birmingham📍 Gilbert📍 Phoenix ECOG-ACRIN Cancer Research Group · Tests: Bevacizumab, Capecitabine, Cetuximab, Computed Tomography, Floxuridine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy